| Long name: |
MYRF/C11orf9 Primary Polyclonal Antibody |
| Also known as: |
MYRF/C11orf9 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
MYRF/C11orf9 |
| Specificity: |
This is a highly specific antibody against MYRF/C11orf9 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen range: |
465-515/1151 |
| Subcellular location: |
Nucleus, Cytoplasm |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human MYRF |
| Gene ID number: |
745 |
| Swiss Prot: |
Q9Y2G1 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
C-terminal: Membrane-bound part that has no transcription factor activity and remains attached to the endoplasmic reticulum membrane following cleavage, MAG and PLP1 during oligodendrocyte (OL) maturation, MOG, Mediates the autocatalytic cleavage that releases the Myelin regulatory factor, Myelin regulatory factor, Myelin regulatory factor, N-terminal component that specifically activates transcription of central nervous system (CNS) myelin genes (PubMed:23966832), N-terminal: Transcription factor that specifically activates expression of myelin genes such as MBP, Not only required during oligodendrocyte differentiation but is also required on an ongoing basis for the maintenance of expression of myelin genes and for the maintenance of a mature, Specifically recognizes and binds DNA sequence 5'-CTGGYAC-3' in the regulatory regions of myelin-specific genes and directly activates their expression, thereby playing a central role in oligodendrocyte maturation and CNS myelination, viable oligodendrocyte phenotype (PubMed:23966832), Myelin regulatory factor: Consitutes a precursor of the transcription factor |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
C11orf9, KIAA0954, MYRF, Myelin gene regulatory factor, Myelin regulatory factor, Ndt80, pqn-47, MRF |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
MYRF/C11orf9 |
| Short name: |
MYRF/C11orf9 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
MYRF/C11orf9 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
1181 |
| Gene: |
MYRF |
More about : MYRF |
| Long gene name: |
myelin regulatory factor |
| Synonyms gene: |
C11orf9 |
| Synonyms gene name: |
chromosome 11 open reading frame 9 |
| Synonyms: |
Ndt80 pqn-47 MRF |
| Synonyms name: |
myelin gene regulatory factor |
| Locus: |
11q12, 2 |
| Discovery year: |
1998-07-30 |
| Entrez gene record: |
745 |
| Pubmed identfication: |
10828591 12384578 |
| RefSeq identity: |
NM_013279 |
| Havana BLAST/BLAT: |
OTTHUMG00000168161 |